Pulmatrix (PULM) Competitors

Chimerix (NASDAQ:CMRX) and Pulmatrix (NASDAQ:PULM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, community ranking, earnings and dividends.

Do institutionals and insiders hold more shares of CMRX or PULM?

45.4% of Chimerix shares are owned by institutional investors. Comparatively, 11.8% of Pulmatrix shares are owned by institutional investors. 13.1% of Chimerix shares are owned by insiders. Comparatively, 0.6% of Pulmatrix shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Do analysts recommend CMRX or PULM?

Chimerix presently has a consensus target price of $8.50, suggesting a potential upside of 865.91%. Given Chimerix's stronger consensus rating and higher probable upside, research analysts plainly believe Chimerix is more favorable than Pulmatrix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chimerix	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Pulmatrix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has more volatility and risk, CMRX or PULM?

Chimerix has a beta of 1.13, indicating that its stock price is 13% more volatile than the S&P 500. Comparatively, Pulmatrix has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500.

Does the media refer more to CMRX or PULM?

In the previous week, Pulmatrix had 3 more articles in the media than Chimerix. MarketBeat recorded 7 mentions for Pulmatrix and 4 mentions for Chimerix. Chimerix's average media sentiment score of 0.83 beat Pulmatrix's score of 0.32 indicating that Chimerix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chimerix	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pulmatrix	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has preferable valuation & earnings, CMRX or PULM?

Pulmatrix has higher revenue and earnings than Chimerix. Pulmatrix is trading at a lower price-to-earnings ratio than Chimerix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chimerix	$320K	247.34	-$82.10M	-$0.94	-0.94
Pulmatrix	$7.30M	2.81	-$14.12M	-$2.64	-2.13

Is CMRX or PULM more profitable?

Chimerix has a net margin of 0.00% compared to Pulmatrix's net margin of -96.51%. Pulmatrix's return on equity of -45.97% beat Chimerix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chimerix	N/A	-50.78%	-44.94%
Pulmatrix	-96.51%	-45.97%	-30.72%

Does the MarketBeat Community believe in CMRX or PULM?

Chimerix received 195 more outperform votes than Pulmatrix when rated by MarketBeat users. Likewise, 63.68% of users gave Chimerix an outperform vote while only 49.00% of users gave Pulmatrix an outperform vote.

Company	Underperform	Outperform
Chimerix	Outperform Votes 391 63.68%	Underperform Votes 223 36.32%
Pulmatrix	Outperform Votes 196 49.00%	Underperform Votes 204 51.00%

Summary

Chimerix beats Pulmatrix on 13 of the 18 factors compared between the two stocks.